OSIRIS THERAPEUTICS INC NEW's ticker is OSIR and the CUSIP is 68827R108. A total of 64 filers reported holding OSIRIS THERAPEUTICS INC NEW in Q3 2013. The put-call ratio across all filers is 1.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,675,000 | +20837.5% | 88,142 | +14002.7% | 0.00% | – |
| Q4 2018 | $8,000 | +166.7% | 625 | +150.0% | 0.00% | – |
| Q3 2018 | $3,000 | -99.8% | 250 | -99.9% | 0.00% | – |
| Q4 2016 | $1,486,000 | +3202.2% | 302,690 | +3248.7% | 0.00% | – |
| Q3 2016 | $45,000 | +9.8% | 9,039 | +12.8% | 0.00% | – |
| Q2 2016 | $41,000 | -89.4% | 8,014 | -88.2% | 0.00% | – |
| Q1 2016 | $386,000 | -11.7% | 67,654 | +60.8% | 0.00% | – |
| Q4 2015 | $437,000 | +152.6% | 42,064 | +351.3% | 0.00% | – |
| Q3 2015 | $173,000 | -88.6% | 9,320 | -88.1% | 0.00% | -100.0% |
| Q2 2015 | $1,523,000 | -6.6% | 78,217 | -15.7% | 0.00% | 0.0% |
| Q1 2015 | $1,631,000 | +226.9% | 92,741 | +197.4% | 0.00% | – |
| Q4 2014 | $499,000 | +27.6% | 31,180 | +0.5% | 0.00% | – |
| Q3 2014 | $391,000 | -21.5% | 31,020 | -2.7% | 0.00% | – |
| Q2 2014 | $498,000 | +100.0% | 31,897 | +67.5% | 0.00% | – |
| Q1 2014 | $249,000 | +156.7% | 19,040 | +215.5% | 0.00% | – |
| Q4 2013 | $97,000 | -93.0% | 6,035 | -92.8% | 0.00% | -100.0% |
| Q3 2013 | $1,395,000 | +1254.4% | 83,848 | +720.0% | 0.00% | – |
| Q2 2013 | $103,000 | – | 10,225 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|